Michael L Peterson
CIK 1293970 · Chief Executive Officer · last filed 2025-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PED price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DANVILLE, CA 94526
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Wellgistics Health, Inc. (WGRX) Delisted | Director | 200,000 | $3.52 | $704.0K | $0 | 1 | 2025-07-08 |
| TPET | Chief Executive Officer | 6,583 | $1.59 | $10.5K | $0 | 2 | 2023-10-30 |
| Ocean Biomedical, Inc. (OCEAW) Delisted | Director | 80,000 | $0.03 | $2.4K | $0 | 1 | 2023-03-02 |
| MEDS | Director | 159 | $2.00 | $317 | -$17.7K | 6 | 2023-01-20 |
| PED | President and CEO | 22,130 | $15.53 | $343.7K | -$702.1K | 25 | 2018-06-29 |
Recent Filings · Page 3 of 5
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-30 | PED | Mixed | +1,600,000 | $173.0K | EDGAR |
| 2016-12-30 | PED | Mixed | +1,600,000 | $173.0K | EDGAR |
| 2016-10-12 | PED | Sell (S) | −15,000 | -$2.7K | EDGAR |
| 2016-09-09 | PED | Sell (S) | −32,500 | -$5.6K | EDGAR |
| 2016-08-11 | PED | Sell (S) | −24,375 | -$5.3K | EDGAR |
| 2016-07-11 | PED | Mixed | −268,565 | -$64.2K | EDGAR |
| 2016-04-29 | PED | Mixed | −282,755 | -$72.0K | EDGAR |
| 2016-01-08 | PED | Mixed | +500,000 | $74.1K | EDGAR |
| 2015-04-10 | PED | Sell (S) | −20,000 | -$10.4K | EDGAR |
| 2015-04-03 | PED | Mixed | −79,500 | -$34.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.